Mega Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	459.45	490.26	518.29	399.83	239.1	208.45
Short-Term Investments	-	2.9	7.98	8.7	223.53	5.8
Cash & Short-Term Investments	459.45	493.16	526.27	408.53	462.63	214.25
Cash Growth	-9.72%	-6.29%	28.82%	-11.69%	115.93%	227.61%
Accounts Receivable	91.94	90.06	115.88	184.82	203.63	130.23
Other Receivables	-	-	-	5.53	0.04	0.71
Receivables	91.94	90.06	115.88	190.36	203.67	130.94
Inventory	5.35	4.61	4.41	3.51	3.28	2.97
Prepaid Expenses	-	17.14	1.84	-	-	-
Other Current Assets	22.51	20.63	19.38	16.69	15.78	9.95
Total Current Assets	579.25	625.59	667.78	619.08	685.36	358.11
Property, Plant & Equipment	75.68	79.26	94.05	46.91	51.13	62.24
Long-Term Investments	30.8	30.8	29.6	30.03	30.2	30.14
Other Intangible Assets	0.69	0.77	0.92	0.83	0.81	0.65
Long-Term Deferred Tax Assets	1.6	2.06	4.2	5.97	2.81	2.06
Other Long-Term Assets	-	-	-	2.88	1.88	0.37
Total Assets	688.02	738.48	796.54	705.7	772.18	453.57
Accounts Payable	25.38	28.8	39.69	34.76	29.2	26.88
Accrued Expenses	-	7.55	6.58	7.95	15.68	7.17
Current Portion of Long-Term Debt	2.04	2	1.91	-	-	2.65
Current Portion of Leases	-	-	5.99	6.48	6.22	8.44
Current Income Taxes Payable	1.37	1.72	0.6	0.12	6.53	0.2
Current Unearned Revenue	0.6	49.22	52.87	10.46	10.7	11.5
Other Current Liabilities	8.77	1.35	2.06	21.48	1.47	205.52
Total Current Liabilities	38.15	90.64	109.71	81.25	69.79	262.37
Long-Term Debt	17.7	18.73	20.72	-	-	-
Long-Term Leases	20.12	13.68	19.94	4.51	5.35	11.66
Long-Term Unearned Revenue	0.45	0.75	1.35	1.95	2.55	3.15
Total Liabilities	76.42	123.8	151.72	87.7	77.69	277.18
Common Stock	0.15	0.15	0.15	0.16	0.13	-
Additional Paid-In Capital	276.05	334.37	385.57	394.49	228.69	-
Retained Earnings	203.97	6.38	6.38	101.63	119.24	40.23
Treasury Stock	-	-27.98	-1.57	-	-	-
Comprehensive Income & Other	131.44	301.77	254.3	121.72	346.44	136.17
Shareholders' Equity	611.6	614.68	644.83	618	694.5	176.4
Total Liabilities & Equity	688.02	738.48	796.54	705.7	772.18	453.57
Total Debt	39.86	34.4	48.56	10.99	11.57	22.76
Net Cash (Debt)	419.59	458.75	477.71	397.55	451.06	191.49
Net Cash Growth	-10.25%	-3.97%	20.16%	-11.86%	135.56%	570.85%
Net Cash Per Share	2.05	2.21	2.26	1.93	3.54	-
Filing Date Shares Outstanding	224.3	228.13	237.77	239.23	200	-
Total Common Shares Outstanding	224.3	228.13	237.77	239.23	200	-
Working Capital	541.1	534.95	558.07	537.83	615.57	95.74
Book Value Per Share	2.73	2.69	2.71	2.58	3.47	-
Tangible Book Value	610.91	613.91	643.91	617.16	693.69	175.74
Tangible Book Value Per Share	2.72	2.69	2.71	2.58	3.47	-
Land	-	34.74	-	-	-	-
Machinery	-	73.04	72.71	69.91	68.6	66.19
Construction In Progress	-	-	34.74	-	-	-
Leasehold Improvements	-	12.95	12.51	11.33	8.63	8.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.